Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Hoffmann-La Roche
Age
50–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
For women of childbearing potential: agreement to remain abstinent (refrain from heterosexual intercourse) or use contraceptive methods that result in a failure rate of less than (\<) 1 percent (%) per year for at least 30 days after the last fluorescein dye administration
The study is being conducted in participants with GA in both Study Eye and Non-Study Eye (bilateral GA) with no evidence of prior or active choroidal neovascularization (CNV)
You may not be if
Previous participation in any studies of investigational drugs for GA or dry AMD (except for studies of vitamins and minerals)
GA in either eye due to causes other than AMD
History of vitrectomy surgery, submacular surgery, or any surgical intervention for AMD
Any ocular or systemic medical conditions that, in the opinion of the investigator, could contribute to participant's inability to participate in the study or interfere with study assessments
Requirement for continuous use of therapy indicated in Prohibited Therapy in the study Protocol
Clareo Health | A Study of Disease Progression in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
